4//SEC Filing
HOLMLUND JON T 4
Accession 0000899243-20-029545
CIK 0001563577other
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 5:56 PM ET
Size
8.7 KB
Accession
0000899243-20-029545
Insider Transaction Report
Form 4
HOLMLUND JON T
Chief Medical Officer
Transactions
- Sale
Common Stock
2020-10-26$15.00/sh−2,244$33,660→ 0 total - Exercise/Conversion
Stock Option
2020-10-26−2,244→ 108,898 totalExercise: $2.43Exp: 2026-03-31→ Common Stock (2,244 underlying) - Exercise/Conversion
Common Stock
2020-10-26$2.43/sh+2,244$5,453→ 2,244 total
Footnotes (2)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 18, 2019.
- [F2]The option has fully vested and is currently exercisable.
Documents
Issuer
Galera Therapeutics, Inc.
CIK 0001563577
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001227367
Filing Metadata
- Form type
- 4
- Filed
- Oct 27, 8:00 PM ET
- Accepted
- Oct 28, 5:56 PM ET
- Size
- 8.7 KB